EVALUATE THE CONCENTRATION OF SERUM CFDNA AND INTEGRITY AS A NON-INVASIVE MARKER TO DISTINGUISH BETWEEN MALIGNANT AND BENIGN BREAST LESION. RJDNMD [Internet]. 2024 Feb. 27 [cited 2024 May 18];31(1):366-89. Available from: https://jrdiabet.ro/index.php/RJDNMD/article/view/304